SubHero Banner
Text

3rd Quarter 2020

Key topics in this quarter’s edition include:

  • Berotralstat, an oral treatment for hereditary angioedema
  • Roxadustat for anemia of chronic kidney disease 
  • Relugolix for advanced prostate cancer
  • Viloxazine, a non-stimulant for attention deficit hyperactivity disorder

Download PDF

Text